Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 12Urinary Bladder Neoplasms 1Renal Insufficiency 1Prostate Adenocarcinoma 1Neoplasm Metastasis 1Melanoma 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Adenocarcinoma 1

Interventions

enzalutamide 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Biopsy 2relugolix 1luprolide acetate gel depot 1gallium 68 PSMA-11 1abiraterone 1X-Rays 1Radium-223 1Radiotherapy, Image-Guided 1Radiotherapy 1Radiation 1Prednisone 1Lymph Node Excision 1Glutamate Carboxypeptidase II 1Abiraterone Acetate 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Prostate Adenocarcinoma × gallium 68 PSMA-11 × Clear all
NCT06044857 2026-04-14

PSMA PET Response Guided SabR in High Risk Pca

University of Texas Southwestern Medical Center

Phase 1 Recruiting
20 enrolled
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡